CompaniesByCap
BBOT
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare

BridgeBio Oncology Therapeutics, Inc. Price to FCF Ratio 2025–2026

Price to free cash flow (P/FCF) ratio for BridgeBio Oncology Therapeutics, Inc. (BBOT): market cap divided by trailing twelve-month free cash flow. As of it is —.
From: 09/30/2025To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF

BridgeBio Oncology Therapeutics, Inc. Price to FCF Ratio — FAQ

BridgeBio Oncology Therapeutics, Inc. (BBOT) price to fcf ratio over the last 3 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BBOT's price to fcf ratio history?

The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s price to fcf ratio by year and by quarter, including the growth rate.